CorrlensCorrlens
Correlate

Correlation Analysis

Nvidia Corp vs Vertex Pharmaceuticals Inc

NVDA vs VRTX

+0.808

Strong positive

When one moves up, the other tends to follow.

NVDA logo

Nvidia Corp

NVDA

Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence to run large language models. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.

Market cap 4.3T

VRTX logo

Vertex Pharmaceuticals Inc

VRTX

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Market cap 110.5B · 6,400 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 observationsStockStockTechnologyHealthcare

Time Series

Rebased to 100

Green: NVDAGray: VRTX36 of 1,254 points (sampled)

Who Moves First

VRTX leads NVDA by 6 days

VRTX tends to move before NVDA.

Best correlation after shifting: +0.811 (13 shifts scanned)

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.279

14 periods · Return correlation when both series rose

Both Falling

+0.322

5 periods · Return correlation when both series fell

Diverging

-0.475

16 periods · Return correlation when series moved apart

R-Squared

65.4%

Share of variance in one series explained by the other.

Trend Agreement

56.0%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.788, 0.827]

Scatter

XY Regression

-1.7050100150200218161.2200250300350400450500512.3Nvidia CorpVertex Pharmaceuticals IncData pointsFit (r = 0.808)

Pipeline

Data quality details

Pipeline Summary

1,254 paired observations survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

NVDA logo

Nvidia Corp

NVDA

Market cap 4.3T

Stock · 1,254 raw → 1,254 prepared

Series B

VRTX logo

Vertex Pharmaceuticals Inc

VRTX

Market cap 110.5B · 6,400 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

42

Estimated crossover points between normalized spreads.

Slope

1.3009

Linear regression slope.

Intercept

256.2094

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 3 hours ago · ID: stock-nvda-vs-stock-vrtx-daily-20260408-a4ni16